Apply Now

News

Mc 9

University of Notre Dame to host Indiana CTSI retreat

Author: Brandi Klingerman

Indiana University, Purdue University, and the University of Notre Dame invite all researchers to attend the Indiana Clinical and Translational Sciences Institute (CTSI) retreat. The event will take place at the University of Notre Dame’s McCourtney Hall on Friday, October 26, 2018 from 9:00 a.m. to 4:15 p.m.
Brian Baker Feature

Study uncovers new hurdle for developing immunotherapies

Author: Deanna Csomo McCool

The discovery made by Notre Dame researchers and their collaborators tosses a new wrench into the process of building better molecules to develop immunotherapies.
Asem2

Director's Message, Fall 2018

Author: M. Sharon Stack, PhD

September is National Ovarian Cancer Awareness month.  Many of us will wear the color teal in the form of ribbons, wristbands, headscarves and other gear in support of women with…
Besansky

What makes a good malaria vector?

Author: Carin Moonin

Nora J. Besansky, the O'Hara Professor and Associate Chair in the Department of Biological Sciences, hypothesizes in a recent paper in the Proceedings of the National Academy of Sciences that if scientists can understand what makes a small group of Anopheles mosquito a strong malaria vector, then perhaps we can prevent the...
Rlac Digital Sign Horizontal Fall 2018

$12,500 Student Grant Opportunity - Fall Deadline: October 1, 2018

Author: Sarah Chapman

The Research Like A Champion (RLAC) Program is offering $12,500 to any and all students who are interested in cancer research. For those of you who are not familiar with the RLAC Program, it is a collaborative effort within the …
Super Resolution Web Image

NDIIF Town Hall Meeting

Author: Sarah Chapman

Join us for a campus-wide town hall event for the NDIIF.  The emphasis of the Town Hall will be on Research, Education, Partnership, and Impact. 
Troponinvimentin Feature

Will heart cells help solve our most complex problems?

Author: Jessica Sieff

As part of a new study, researchers at the University of Notre Dame aim to create a more optimal computer network for solving complex problems — using heart cells.
Brian Baker

Notre Dame Startup Structured Immunity and Medigene Announce Collaboration Aimed at Improving T Cell Receptor Development

Author: Nick Swisher

Structured Immunity, a Notre Dame startup and biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins, and Medigene AG, a leading biotechnology company engaged in the development of immunotherapies for the treatment of cancer, today announced a research collaboration where Structured Immunity will provide structural immunology expertise...